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SUMMARY
Mislocalization, cleavage, and aggregation of the human protein TDP-43 is found
in many neurodegenerative diseases. As is the case with many other proteins
that are completely or partially structurally disordered, production of full-length
recombinant TDP-43 in the quantities necessary for structural characterization
has proved difficult. We show that the full-length TDP-43 protein and two trun-
cated N-terminal constructs 1-270 and 1-263 can be heterologously expressed
in E. coli. Full-length TDP-43 could be prevented from aggregation during purifi-
cation using a detergent. Crystals grown from an N-terminal construct (1-270) re-
vealed only the N-terminal domain (residues 1-80) with molecules arranged as
parallel spirals with neighboring molecules arranged in head-to-tail fashion. To
obtain detergent-free, full-length TDP-43 wemutated all six tryptophan residues
to alanine. This provided sufficient soluble protein to collect small-angle X-ray
scattering data. Refining relative positions of individual domains and intrinsically
disordered regions against this data yielded a model of full-length TDP-43.
INTRODUCTION
The deposition of intracellular TDP-43 inclusions is the hallmark of TDP-43 pathology. Initially observed in
neural tissues from individuals with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral
sclerosis (ALS) (Neumann et al., 2006), TDP-43 pathology is now associated with many neurodegenerative
diseases. These include, but are by nomeans limited to, Alzheimer disease (Amador-Ortiz et al., 2007), Par-
kinson disease (Nakashima-Yasuda et al., 2007), hippocampal sclerosis (Amador-Ortiz et al., 2007), and
chronic traumatic encephalopathy (McKee et al., 2010). Mixed pathology is common with these diseases,
and TDP-43 pathology can be found not only alongside Lewy bodies (Nakashima-Yasuda et al., 2007), am-
yloid-b plaques, and tau tangles (Amador-Ortiz et al., 2007) in cases of neurodegenerative disease but also
in clinically normal aged individuals (Wennberg et al., 2019).
TDP-43 protein has several functions, and its modular structure facilitates this multitasking. Two centrally
located RNA recognition motifs (RRM) strongly bind UG-rich RNA (Lukavsky et al., 2013) or TG-rich DNA
(Austin et al., 2014) directing TDP-43 to pre-mRNAs and intronic sites (Tollervey et al., 2011). Through these
protein-nucleic acid interactions TDP-43 facilitates RNA transport (Fallini et al., 2012) and directly effects
splicing of a multitude of RNAs including those coding for many ALS-associated heterogeneous nuclear
ribonucleoprotein particles (Deshaies et al., 2018) and TDP-43 itself (Ayala et al., 2011). A low-complexity
domain, situated C terminal to the RRM domains, is involved in stress granule formation following cellular
stress (Colombrita et al., 2009). This domain undergoes liquid-liquid phase transitions and complexes with
other TDP-43 molecules (Li et al., 2018a) or other intrinsically disordered proteins (McDonald et al., 2011),
whereas RRM domains trap mRNAs to assist selective translation during and following stress. Many single
amino acid substitutions within the C-terminal domain are known to cause ALS and FTLD, indicating that
aberrant stress granule dynamics may lie at the heart of TDP-43 proteotoxicity (Wolozin, 2012). At the N
terminus, a ubiquitin or dix-like domain (Mompeán et al., 2016; Qin et al., 2014) provides a polymerization
surface that enables formation of dimer and higher-order oligomers predominantly found in the cell
nucleus (Afroz et al., 2017).
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In addition to the domains described earlier, TDP-43 also contains nuclear export and import sequences
that flank the RRM domains. In the full-length form, this enables shuttling of the protein between the nu-
cleus and cytoplasm (Ayala et al., 2008). Observation of TDP-43 inclusions in FTLD and ALS brain tissues
has shown that it is fragmented (Neumann et al., 2006) with a 25-kDa cleavage product being themost com-
mon but 15- and 35-kDa forms are also seen. The common element present in these cleavage products is
the low-complexity C-terminal domain. In this state, the nuclear localization signal is lost and the protein
remains cytoplasmic and aggregates through the low-complexity C-terminal domain. The normal functions
and misfunction of TDP-43 are therefore predicated by its propensity to oligomerize and aggregate. This
property makes in vitro characterization difficult, particularly using structural techniques that require mono-
disperse samples at relatively high concentrations. The modularity of TDP-43 means that individual
domains can be produced recombinantly to shed light on their organization and structure-property rela-
tionship. This approach has been well utilized to gain insight on dimerization (Afroz et al., 2017), RNA bind-
ing (Lukavsky et al., 2013), and thermal stability (Austin et al., 2014; Chiang et al., 2016). However, to go
beyond individual domains and gain a holistic understanding of TDP-43 structure we tested several
strategies to produce pure, full-length TDP-43. Using sarkosyl detergent and mutagenically removing
tryptophan resides (TDP-43WtoA), we were able prevent recombinant TDP-43 aggregation during protein
preparation in each of these cases. We produced sufficient quantities of detergent-free TDP-43WtoA for
small-angle X-ray scattering (SAXS) analysis allowing us to create a model of full-length TDP-43.
RESULTS
Recombinant Expression and Purification of Full-Length and C-Terminal Truncated TDP-43
On heterologous expression of full-length wild-type TDP-43 in E. coli followed by cell lysis and centrifuga-
tion, we found the protein in the insoluble fraction as has previously been described (Furukawa et al., 2011).
Figure 1. Purification of Full-Length Wild-Type TDP-43 Using 0.2% Sarkosyl
(A) Cell lysis in 50 mM sodium phosphate pH 8.0, 300 mM sodium chloride, 5 mM imidazole, 5 mMdithiothreitol, complete
protease inhibitor cocktail, 1 mM phenylmethylsulphonyl fluoride, 50 mg/mL lysozyme, and pure water. SF, soluble
fraction; IF, insoluble fraction.
(B) Immobilizedmetal ion chromatography. SF, soluble fraction; FT, flowthrough; wash fraction (75 mM imidazole), elution
with increasing imidazole concentration.
(C) Size exclusion chromatography (SEC) and SDS-PAGE of SEC fractions containing pure wild-type TDP-43.
ll
OPEN ACCESS
2 iScience 23, 101159, June 26, 2020
iScience
Article
However, low-temperature expression followed by cell lysis in pure water yielded segregation of the
protein roughly equally between soluble and insoluble fractions but made affinity purification problematic.
This is possibly an indication that recombinant TDP-43 is not localized to inclusion bodies when expressed
in bacteria. To solve this problem, 0.2% sodium lauroyl sarcosinate (sarkosyl) was added to the cell lysate
and used in all purification buffers. This yielded 5.3 mg of pure, soluble protein for a litre of culture (Fig-
ure 1). This detergent-solubilized protein is stable without visible aggregation after a week at 4C or a
freeze/thaw cycle.
Several constructs of C-terminal truncated TDP-43 (N-terminal 1-263, 1-270, 1-290, 1-320, and several single
point mutations of 1-270 fragment including A90V, D169G, K263E, and N267S) were prepared and evalu-
ated. The N-terminal 1-270 wild-type construct provided stable purified protein (Figure 2) and was pursued
for further investigations. This was used for crystallization experiments from which structure of N-terminal
domain (NTD) (1-80) was obtained.
Addition of soluble fusion domains is a common technique used to enable production of recombinant pro-
teins. Wang et al. (2018) added a maltose-binding protein fusion to TDP-43 directly C terminal to the low-
complexity domain where it effectively increased solubility. To obtain detergent-free TDP-43 without
recourse to fusions proteins, and with the knowledge that several TDP-43 tryptophan residues are involved
in folding (Prakash et al., 2018) and phase transitioning (Li et al., 2018a, 2018b), together with the role of
aromatic residues in low-complexity aromatic-rich kinked segment formation (Hughes et al., 2018), we
created a construct where all tryptophan residues in the TDP-43 primary sequence are replaced with
alanine (TDP-43WtoA). Cell lysis and protein purification with standard immobilized metal ion chromatog-
raphy buffers without any detergent facilitated production of full-length TDP-43WtoA that was stable for
3 days at 4C (Figure 3), sufficient to undertake non-crystallographic structural studies.
Crystallization of the N-Terminal TDP-43 Dimerization Domain
To elucidate the molecular basis of TDP-43 pathogenesis, a stable N-terminal 1-270 fragment was used for
crystallization and formed crystals when grown at 19C. The structure provided a surprise as only the NTD
(1-80) was visible. Analysis of several crystallization drops by SDS-PAGE indicated the 30-kDa original
protein to have shifted to approximately 23 kDa, which would indicate cleavage of RRM2. During 1 week
of crystallization the protein appears to have auto-cleaved. The TDP-43 NTD crystallized in space group
P212121 with five identical molecules in the asymmetric unit. The structure was solved by molecular replace-
ment and refined to 2.55 Å resolution (Table 1). The NTD adopts a similar conformation as reported in a
Figure 2. Purification of Wild-Type TDP-43 Residues 1-270
(A) Nickel-nitriloacetic acid (NiNTA)-immobilized metal ion chromatography (IMAC). SF, soluble fraction; FT,
flowthrough; wash (5 mM imidazole); 75 mM/150 mM elution imidazole concentration.
(B) Size exclusion chromatography.
(C) Fractions from (B) containing pure wild-type TDP-43 residues 1-270.
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recent crystallographic structure obtained in P63 space group (Afroz et al., 2017). A compact five-stranded
b-sheet fold was observed with a two-turn alpha helix (Figures 4A–4C), and the negatively charged tail of
each domain is packed against the positively charged C-terminal part (head-to-tail interaction).
The head-to-tail interfaces between the molecules differ from those reported previously (Afroz et al., 2017).
A sulfate ion binds at the interface between the molecules and is bonded to Arg52 and Arg55, which serves
as a wedge, increasing the distance between the monomers. This binding of a sulfate ion to Arg52 and
Arg55 (Figure 4D) rearranges their side chains preventing strong bonding between Arg52-Glu3 and
Arg55-Glu21 reported in an earlier NTD structure (Afroz et al., 2017). These change the position of the N
terminus toward the interface (Figures 4D and 4E), moving the Glu3 side chain away from Arg52 andmaking
strong salt bonding with Arg52 impossible. The changes in the position of themonomers against each other
alter the superhelical bundle arrangement observed previously (Afroz et al., 2017) (Figure S1). In our struc-
ture, bundles of the tight spirals are packed against six neighboring spirals (Figure S1C). Each spiral, with
radius of 46 Å, has 10 NTD molecules in a full turn (Figures 4A, 4B, S1A, and S1B) with distance between
two rings being ~36 Å. Analysis of the structural changes on sulfate binding confirms that ligand binding
at the molecular interface could change the nature of the helical arrangements. These head-to-tail interac-
tions that lead to parallel spirals are consistent with the view that physiological TDP-43 oligomerization is
mediated by its NTD and may be key to prevent the formation of pathologic aggregates.
Structural Characterization of Full-Length Tryptophan-Free TDP-43
Solvent-accessible tryptophan residues within intrinsically disordered regions are unlikely to contribute to
individual domain structures. It is, however, important to understand the perturbations caused by muta-
tion of tryptophans within the NTD and RRM1 domain. Available RRM1 structures (Kuo et al., 2014; Lukav-
sky et al., 2013) show Trp178 has a role in nucleic acid binding but in the apo form both Trp113 and
Trp172 side-chains protrude into solvent. Comparing tryptophan solvent accessible surface area in
various proteins taken from a non-redundant database of 27,015 protein structures (He et al., 2014) indi-
cates the RRM1 tryptophans to be unusually exposed (Figure 5). Thus, mutation of these residues is un-
likely to change the overall RRM1 structure. The side chain of Trp68, found in NTD loop 5 adjacent to the
domain core, forms hydrophobic interactions with other residues within the core (Figure S2) (Mompeán
et al., 2016) and may support a homodimer interface (Afroz et al., 2017). Indeed, reducing
Figure 3. Purification of Full-Length TDP-43WtoA
(A) NiNTA IMAC. SF, soluble fraction; FT, flowthrough; wash (5 mM imidazole); 80 mM/150 mM elution imidazole
concentration.
(B) Size exclusion chromatography (SEC).
(C) SEC fractions containing pure TDP-43WtoA.
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homodimerization propensity may have aided our recovery of soluble and relatively stable full-length pro-
tein. Trp68 retains some solvent exposure (Figure 5), is surrounded by loop regions, whose mutation is
thus unlikely to affect secondary structural elements that contribute to overall domain tertiary structure.
Using the expression protocol described above, and elaborated upon in the Transparent Methods sec-
tion, we were able to produce sufficient detergent-free recombinant TDP-43WtoA to perform chromato-
graphic SAXS experiments. Size exclusion chromatograms of full-length TDP-43 (Figure S3) are slightly
asymmetric. This could be interpreted as a fast oligomeric equilibrium, between monomer and dimer,
for example, or an interaction with column media, which delays elution of some molecules. Sampling
data points in the first and last thirds of a single TDP-43WtoA elution indicates a decrease in mean radius
of gyration (Rg) from 41.8 G 3.5 Å to 38.9 G 4.0 Å (Figure S3). Owing to this small change in Rg, and lack
of distinct sub-populations within each profile, we averaged the data across two full TDP-43WtoA elutions.
This yielded good-quality data over an angular range of 0.0084–0.35 Å1 (Figure 6A). Inspection of the
TDP43
Data Collection
Space group P21 21 21
Cell dimensions
a, b, c (Å) 34.637, 95.224, 157.558
a, b, g () 90.00, 90.00, 90.00





















Bond lengths (Å) 0.0040
Bond angles () 1.256
PDB 6T4B
Table 1. Crystallographic Data Collection and Refinement Statistics
avalues in paranthesis are for the outer shell of data
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Guinier plot (Figure 6B) indicates that TDP-43WtoA is not aggregated and has Rg 41.1 Å. Rendering the
experimental data as a dimensionless Kratky plot shows TDP-43WtoA to have a high degree of unfolding
but to not be completely disordered (Figure 6C). This is expected given the presence of previously
characterized modular nucleic acid binding and dimerization domains (Afroz et al., 2017; Austin et al.,
2014; Lukavsky et al., 2013). Assignment of largest intramolecular distances (Dmax) is difficult for disor-
dered proteins, and this is the case for TDP-43WtoA, with possible Dmax values ranging from 132 to 180 Å
(Figure 6D).
Using available structures for RRMs, dimerization, and helical domains in conjunction with linker peptides
synthesized in silico we generated initial models of full-length TDP-43WtoA (Figure S4) and refined them
against our experimental SAXS data to yield a conformationally optimized model (Figure 7A). The mono-
mericmodel generated has little contact between domains except between theNTD and RRM2 (Figure 7B).
Calculation of its scattering profile indicates a very good fit to the experimental data c2 1.1 (Figure 7C). The
experimentally determined Rg agrees with the model within 0.8 Å (41.1 and 41.9 Å, respectively). Compar-
ison of the distance distribution functions of our monomeric, full-length TDP-43WtoA model with that
derived from experimental data also indicates exceptionally good correlation (Figure 7D). Models of
TDP-43WtoA where dimerization was enforced through the NTD had consistently poor fit to the experi-
mental data, c2 of 1.5 and Rg 49.7 Å.
Figure 4. Crystal Structure of TDP-43 NTD at 2.55 Å Resolution
Molecules of TDP-43 NTD are arranged in the crystal as parallel spirals.
(A) Filaments from neighboring molecules arranged in head-to-tail fashion. Atoms of 10 molecules comprising two neighboring asymmetric units make one
full turn of the spiral and are shown in different colors. The outside radius of the spiral is ~92 Å, whereas internal radius is 45 Å.
(B) Side view of the spiral, showing two full turns with distance between two turns of the spiral 36.2 Å.
(C) Cartoon representation of two neighboring TDP-43 NTD molecules.
(D) Expanded view of the interface betweenmolecules shown in (C). Amino acid side chains making intermolecular contacts are shown in stick representation
in the corresponding domain color and labeled. Intermolecular hydrogen bonds are shown as dotted black lines.
(E) The dimer interface described by Afroz et al. (2017) (PDB: 5MDI) and labeled as in (C).
(F) Superposition between dimer interfaces shown in (D) and (E). Structures were aligned to one molecule rather than the whole dimer.
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Although the structures of individual domains of TDP-43 have been elucidated using several techniques
that have revealed some aspects of the molecular functions of this protein (Afroz et al., 2017; Chiang
et al., 2016; Guenther et al., 2018; Kuo et al., 2014; Mompeán et al., 2016), the structure of full-length
TDP-43 has been refractory to characterization due to the difficulty of purifying soluble and stable protein
in sufficient amounts for analysis (Johnson et al., 2009; Kitamura et al., 2018; Li et al., 2017). A recent report
overcame this challenge using denaturing conditions, but this could change the native TDP-43 structure
(Vivoli Vega et al., 2019). In this work, we describe full-length wild-type TDP-43 and TDP-43WtoA, both suc-
cessfully purified by non-denaturingmethods. SAXS data of TDP-43WtoA reveal the conformation of the full-
length protein in solution. The region of TDP-43 comprising the NTD, RRM1, and RRM2 adopts a compact
triangular structure, whereas the position of the C terminus is variable.
A fragment of TDP-43 comprising residues 1-270 including NTD and RRMs was used in crystallization
experiments and the structure of the NTD (residues 1-80) was elucidated at 2.55 Å resolution. The pro-
tein appears to have been auto-cleaved at N terminal to RRM2 during the 7 days required for crystal-
lization to produce diffraction-quality crystals, whereas RRM1 is conformationally mobile in crystallo
and therefore not visible. The TDP43 NTD has been reported to be essential for dynamic TDP-43
oligomerization that may prevent the aggregation-prone C terminal from forming pathogenic and irre-
trievable TDP-43 aggregates. This crystal structure shows that the superhelical format arises from head-
to-tail interactions between NTD molecules. The SAXS model implies that the peptide chain linking
NTD and RRM1 domains is longer than other domains, so it is likely to be disordered when forming
higher-order structures.
The ability to obtain full-length TDP-43 in a stable form without denaturing conditions opens possibil-
ities for extensive biophysical studies on both the wild-type and C-terminal mutants, which are
known to exert greater aggregation propensity (Cao et al., 2019). We propose that the approaches
used here may have general applicability and may prove useful for other aggregation-prone
proteins where a significant proportion of the macromolecule is classified as ‘‘unstructured,’’ i.e., having
a lower folding probability. Enabling the purification of stable complexes via mutation of residues that
cause precipitation or aggregation has recently proven key to our description of the functional
complexes between SOD1 and its cognate chaperone (Sala et al., 2019). Similarly, use of detergents
for soluble proteins should enable high-concentration structural studies for such systems, providing
an essential platform for molecular understanding of pathogenic properties and possible therapeutic
solutions.
Figure 5. Distribution of Solvent Accessible Surface Area (SASA) of Tryptophans in a Non-redundant Database of
Protein Structures
SASA for three tryptophan residues found in structured domains of TDP43 is shown in magenta: W68 in the NTD and
W113 and W172 in RRM1. Their cumulative percentile of exposure is 23.6%, 98.5%, and 91.8% respectively.
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Limitations of the Study
A population of intrinsically disordered sequences are, by their nature, very unlikely to simultaneously
occupy the same conformation. Although the model presented in Figure 7A is our best representation
of the TDP-43 structure, it is clearly a snapshot of a very dynamic system. The model presented in Figure 7A
has an unrestrained and predominantly disordered C-terminal region but, as noted, a relatively compact
N-terminal region comprising the NTD, RRM1, and RRM2. Disordered parts of the protein contribute
less to scattering intensity than globular domains and are poorly defined by scattering data. To determine
how variable the spatial arrangement presented in Figure 7A may be, we performed long molecular dy-
namics simulations using our optimized model as a starting structure. Figure 8 shows that positioning of
the disordered C terminus has little effect on the fit to experimental data. However, those structures
that fit the data poorly exhibit an increase in the Rg value for the whole molecule and the Rg representing
NTD, RRM1, and RRM2 domains (amino acids 1-258) (Figures S5A and S5B and Table S1). For these models,
inter-domain linkers are also found in an extended conformation (Figures S5C–S5E and Table S1) and sep-
aration between domains is therefore maximized. Conversely, for models that fit the data well, the globular
domains occupy a compact conformation, whichmatches that presented in Figure 7A (Figures S5A and S5B
Figure 6. Full-Length TDP-43 X-Ray Scattering
(A) Intensity plot of X-ray scattering by TDP-43WtoA.
(B) TDP-43WtoA Guinier plot (upper) and residuals (lower). R
2 0.974 over data range 0.3 < q.Rg < 1.29. Rg = 41.1 G 0.4 Å
(with error stated as SEM) as determined by m = -Rg2/3, where m is the gradient of the line, and I(0) = 8.60 3 103. Both
plots indicate a monodisperse sample with little or no interparticle interference.
(C) Guinier-based dimensionless Kratky plot showing that the peak maximum for TDP-43WtoA is moved away from the
point at O3 and 1.1 (highlighted in red) where globular proteins show a maximum. This is indicative of unstructured
regions. The overall form of the curve, which does not return to the baseline after the initial peak but does not continue to
increase with qRg, is also indicative of a protein with both folded and unfolded regions.
(D) SAXS distance distribution functions (P(r)) for TDP-43WtoA. Multiple possible functions are plausible with a Dmax range
132–180 Å. P(r) functions with Dmax 132–150 Å have real space Rg and I(0) that correlate well with those from the Guinier
approximation, whereas those with Dmax 170–180 Å show smooth transitions with the r scale. Dmax, Rg, and I(0)
determined from each P(r) function are stated in the legend.
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and Table S1). For both well-fitting and poorly fitting model groups the specific orientation of globular do-
mains cannot be accurately defined but the geometry of domain positions can.
Resource Availability
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, S. Samar Hasnain (s.s.hasnain@liverpool.ac.uk).
Figure 7. Model of Full-Length TDP-43 Refined Against SAXS Data
(A) Model of full-length TDP-43WtoA. Model has Rg 41.9 Å and Dmax 154 Å.
(B) Schematic of the above showing center of mass and closest contact intradomain distances.
(C) Model fit to experimental intensity scattering data c2 1.10.
(D) Distance distribution functions for experimental data showing solutions with variable possible Dmax compared with
that for the model.
ll
OPEN ACCESS




All unique and stable reagents generated in this study are available from the Lead Contact without restriction.
Data and Code Availability
The atomic coordinate and structure factor of the NTD (NTD) of TDP-43 have been deposited in the Protein
DataBank (http://www.rcsb.org/) under the accession code 6T4B.
Experimental SAXS data and TDP-43 models are available from the corresponding author on request.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2020.101159.
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Figure 8. Comparison of Full-Length TDP-43WtoAModels with Both Good and Poor Fit to Experimental SAXSData
(A) Ten TDP-43WtoA models with highest goodness of fit to the experimental data from a pool of 7,000 aligned to amino
acids 1-258 of the model presented in Figure 7A.
(B) Ten models with lowest goodness-of-fit to experimental data aligned to amino acids 1-258 of the model with highest c2.
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Figure S1. Arrangement of TDP-43 NTD domains within different crystal forms. Continuous 
spiral with 10 NDTs in one turn of the spiral A) side view of the spiral and, B) top view. C) 
Packing of the crystal from the same direction as B. The identical chains are illustrated in the 
same colour. D) Super-helical arrangement (PDB: 5MDI) from the side and, E) the top. F) 
Packing of the crystals containing filaments. Three different representative filaments 






Figure S2. Hydrogen bond formation and hydrophobic interactions formed by TDP-43 
N-terminal domain Trp68. Trp68 and surrounding residues are shown in cyan and green, 
respectively. Hydrogen bond and hydrophobic contacts are illustrated as black and yellow 






Fig S3. Chromatographic SAXS parameters for TDP-43WtoA. Integrated intensity is plotted 
in blue. Radius of gyration is plotted in red. The slope of the Rg plot is shown as a red line 
which has gradient coefficient -0.13 and R2 0.12. Data points in the first third of the elution 





Figure S4. Comparison of initial models of full-length TDP-43. A and B) Monomeric TDP-




Figure S5. Analysis of goodness-off fit to experimental SAXS data versus size 
parameters for 7000 TDP-43WtoA models. A) The relationship between full-length TDP-43WtoA 
model Rg to c2. B) The relationship between Rg of the N-terminal region of TDP-43WtoA 
molecule comprising amino acids 1-258 (NTD-RRM1-RRM2) to c2. C) The relationship 
between TDP-43WtoA NTD-RRM1 distance and c2. D) The relationship between the TDP-43WtoA 
NTD-RRM2 distance and c2. E) The relationship between the TDP-43WtoA RRM1-RRM2 
distance and c2. Parameters for structures presented in Figure 8A and 8B are highlighted with 










    
c2 1.16 ± 0.01 5.41 ± 0.10 1.10 
Rg of full-length 
TDP43 (Å) 
43.1 ± 1.5 51.8 ± 3.0 41.9 
Rg of amino 
acids 1-258 (Å) 
27.4 ± 2.9 40.2 ± 2.1 25.4 
NTD-RRM1 
distance (Å) 
38.3 ± 5.7 70.0 ± 6.2 48.2 
NTD-RRM2 
distance (Å) 
49.8 ± 15.7 83.5 ± 12.3 28.2 
RRM1-RRM2 
distance (Å) 
36.2 ± 6.7 49.4 ± 4.7 40.3 
 
Table S1. Comparison of size parameters for the models presented in Figures 7 and 8. 






Expression and purification  
 
Full-length wild-type TDP-43 (wtTDP-43) and TDP-43 construct containing W67A, W113A, 
W172A, W334A, W385A and W412A mutations (TDP-43WtoA) were synthesised de novo with 
an N-terminal hexa-his tag and tobacco etch virus (TEV) cleavage site in pET-28a(+) vector. 
This expression plasmid was transformed into BL21 (DE3) E. coli and pre-cultured at 37 oC 
overnight in LB media with 50 µg/ml of kanamycin. 25 ml of this pre-culture was added into 1 
litre of LB media and the culture was incubated at 37 ºC in a shaker until the optical density at 
600nm was 0.7. The culture was cooled for 30 min at 4 oC. IPTG was added to a final 
concentration of 0.5 mM to induce protein expression and the flasks were kept in shaker 
overnight at 18 ºC. The cells were then harvested by centrifugation. 
 
1 g of cells was resuspended in 5 mL water and incubated at 4 oC for 30 minutes before 
sonication on ice. The cell lysate was clarified by centrifugation at 35,000 g for 1 hour before 
adding 50mM sodium phosphate pH 8.0 and 0.2% sarkosyl. A nickel-NTA IMAC column was 
equilibrated with 50 mM sodium phosphate pH 8.0, 300 mM sodium chloride, 5 mM imidazole, 
0.2% sarkosyl prior to application of the soluble fraction at room temperature. Protein was 
eluted from the column with 150-500 mM imidazole in 50 mM sodium phosphate pH 8.0, 300 
mM sodium chloride, 5 mM DTT and dialysed overnight at 4 oC with the addition of TEV 
protease against the same buffer without imidazole. The cleaved protein was then filtered 
through the NiNTA column again with wtTDP-43 now passing directly through. It was then 
concentrated and applied to a Superdex 75 16x600 mm size exclusion chromatography 
column with 0.5 ml/min flow of 20 mM Tris-HCl pH 8.0, 300 mM NaCl, 5 mM DTT, 0.2% 
sarkosyl. Fractions were analysed by SDS-PAGE and those found to contain full-length 
wtTDP-43 were pooled, concentrated and stored at 4 oC. 
 
Full-length TDP-43WtoA and truncated amino acids 1-270 wild-type TDP-43 were expressed 
and purified as above protocol without using sarkosyl, but cell lysis was carried out in 50 mM 
sodium phosphate pH 8.0, 300 mM sodium chloride, 5 mM imidazole, 5 mM DTT, complete 
protease inhibitor cocktail (Roche), 1 mM PMSF, 50 ug/ml lysozyme instead of water. 
 
Crystallisation 
A 1-270 amino acid fragment of TDP-43 protein at 40 mg/ml concentration was crystallised at 
19 oC by the hanging drop method. 1 μL of protein was mixed with 1 μL of ready-made solution 
F2 from PACT premier screen (Molecular Dimentions) and equilibrated over the reservoir 
solution, containing 0.2M Sodium bromide, 0.1M Bis-Tris propane 6.5, 20% PEG 3350. 




Data collection, structure determination and refinement 
Data were collected at DIAMOND synchrotron, beamline I03 using x-rays of 0.9763 Å 
wavelength with PILATUS 6M detector to 2.55 Å resolution. Data were integrated with iMosflm 
(Battye et al., 2011) and scaled with Aimless (Evans, 2011) software as part of the CCP4 
package. The structure was solved by Molrep software (Vagin and Teplyakov, 2010) with 
starting model TDP-43 structure (PDB:5MDI chain A) and refined using Refmac5 (Murshudov 
et al., 2011) with applied NCS symmetry. TLS refinement was implemented towards the end 
of the refinement. Data collection and refinement statistics are presented in Table 1. 
 
Small-angle x-ray scattering data collection 
 
Chromatographic SAXS data for full-length TDP-43WtoA was collected at Diamond Light Source 
on beamline B21. Data was acquired following a chromatographic step where 45 µl of TDP-
43WtoA at 5 mg/ml was loaded onto a Superdex 200 10x300 mm size exclusion 
chromatography column at room temperature. The protein was eluted at a flow rate of 200 
µl/min and directly exposed to x-rays. Blank frames were taken prior to protein elution for 
buffer subtraction purposes. Individual frames recorded over a single chromatography run 
were averaged based on Rg values and overall similarity in a correlation map. Two separate 
chromatography runs were performed and the results of each were averaged to give the final 
scattering profile. Averaging was performed with ScÅtter. The scattering curve of full-length 
TDP-43 was observed in ScÅtter, Primus (Konarev et al., 2003) and Matlab where the Guiner 
approximation was performed and Rg determined. GNOM (Svergun, 1992) was used to 
determine distance distribution functions. 
 
Structure modelling and refinement against SAXS data 
 
An initial model of full-length TDP-43 was constructed from NMR structures of the NTD 
(Mompeán et al., 2016) (2N4P); RRM1 and RRM2 (Lukavsky et al., 2013) (4BS2); and an 
helical structure formed by residues 321-343 in the C-terminal tail (Jiang et al., 2016) (2N3X) 
shown to be partially populated (Conicella et al., 2016). Pepfold (Maupetit et al., 2009) was 
used to generate the remaining linkers between these structured segments and Modloop 
(Fiser and Sali, 2003) was used to link each component to form a continuous polypeptide. 
Tryptophan residues were mutated to alanine using Coot (Emsley and Cowtan, 2004). 
 
Two different starting models were refined against experimental SAXS data using CNS 
(Brunger, 2007), as described previously (Wright et al., 2016, 2018). Domains defined above 
were initially treated as free-floating rigid bodies and inter-domain linkers allowed to move 
freely over 750 ps simulations at 300,000 K. Over the course of the simulation 1000 structures 
were written out and compared with the experimental scattering data with FoXS (Schneidman-
Duhovny et al., 2016). This global refinement of domain positions was followed by fine-tuning 
of the position and orientation of individual domains. Here, the majority of the protein was fixed 
in space while one domain and its surrounding linkers were allowed to move. Each step in this 
process was performed independently with different initial trajectories 6 to 8 times. The 
structure that fit the data best was taken forward for further optimisation. To ensure that 
conformational space had been adequately sampled during this process, a 3.75 ns simulation 
was performed starting from our optimised model with all domains able to move freely. This 
was independently repeated with different seed trajectories 7 times. Domain centres of mass 
were calculated using CNS. 
 
Experimental SAXS data and derived models are available upon request. 
 
Solvent accessible surface area calculations 
 
Apo structures (protein only without nucleic acid or other ligand) are used to calculate the 
SASA of tryptophans in a non-redundant database of 27,015 structures taken from the Protein 
Data Bank using MUFOLD-DB (He et al., 2014), with 70% sequence identity. The SASA of 
amino acids was calculated using tcl scripts in VMD (Humphrey et al., 1996) and confirmed 
using built-in commands in GROMACS  modified with improved resolution of sampling points. 
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